4
Changes in Ownership
Outlook Therapeutics, Inc. Filed Acc 0001209191-16-121073
Chief Medical Officer bought 2,000 shares
From the SEC's structured data for this filing
Trades in this filing
Bahrt Kenneth · Chief Medical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2016-05-13 | Purchase : show line 1 in the form | +2,000 | 2,000 | D |
| Open-market purchases · 2,000 sh | ||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2016-05-13 | Purchase : show line 2 in the form Series A Warrants (right to buy) | +1,000 | $6.60 | 2017-02-18 | 1,000 | 1,000 | D |
| 2016-05-13 | Purchase : show line 3 in the form Series B Warrants (right to buy) | +1,000 | $8.50 | 2018-05-18 | 1,000 | 1,000 | D |
Loading xslF345X03/doc4.xml…